Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Synergistic growth inhibition seen with BEZ-235 and dual EGFR and HER-2/neu inhibitor

Dec. 31, 2009

Activity of nab-rapamycin against breast cancer xenografts enhanced by other agents

Dec. 31, 2009

Tetrathiomolybdate may reduce endothelial progenitor cells in breast cancer patients

Dec. 30, 2009

MVA-BN-HER2 well tolerated, active in phase I breast cancer studies

Dec. 30, 2009

Breast cancer growth inhibition seen with JMR-132 and tamoxifen

Dec. 30, 2009

BTC induces apoptosis in PKCalpha overexpressing breast cancer cells

Dec. 30, 2009

New data indicate ridaforolimus-trastuzumab beneficial in refractory metastatic breast cancer

Dec. 30, 2009

BSI-201 added to gemcitabine/carboplatin improves survival in metastatic TNBC

Dec. 29, 2009

Interim study results suggest AE-37 vaccine may reduce breast cancer recurrence

Dec. 29, 2009

Ipsen discloses preliminary data from phase I trial of BN-83495 in breast cancer

Dec. 29, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...